Barclays’s Clorox CLX Stock Holding History

Barclays’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-350,000	Closed	-$47.8M	–	5315
2024 Q2	$47.8M	Buy	350,000 +300,000	+600%	+$41.7M	0.01%	630
2024 Q1	$7.66M	Hold	50,000	–	–	﹤0.01%	1573
2023 Q4	$7.13M	Sell	50,000 -50,000	-50%	-$6.67M	﹤0.01%	1803
2023 Q3	$13.1M	Buy	+100,000	New	+$15.2M	0.01%	888
2022 Q1	–	Sell	-8,700	Closed	-$1.52M	–	5022
2021 Q4	$1.52M	Hold	8,700	–	–	﹤0.01%	2555
2021 Q3	$1.44M	Hold	8,700	–	–	﹤0.01%	2548
2021 Q2	$1.56M	Hold	8,700	–	–	﹤0.01%	2361
2021 Q1	$1.68M	Buy	+8,700	New	+$1.67M	﹤0.01%	2442
2020 Q4	–	Sell	-1,900	Closed	-$399K	–	4916
2020 Q3	$399K	Sell	1,900 -6,600	-78%	-$1.47M	﹤0.01%	3397
2020 Q2	$1.86M	Sell	8,500 -35,000	-80%	-$6.99M	﹤0.01%	2188
2020 Q1	$7.54M	Buy	43,500 +20,900	+92%	+$3.45M	0.01%	1176
2019 Q4	$3.47M	Sell	22,600 -7,300	-24%	-$1.09M	﹤0.01%	2409
2019 Q3	$4.54M	Buy	29,900 +7,000	+31%	+$1.11M	﹤0.01%	1940
2019 Q2	$3.51M	Buy	22,900 +4,000	+21%	+$611K	﹤0.01%	2246
2019 Q1	$3.03M	Buy	18,900 +10,400	+122%	+$1.61M	﹤0.01%	2134
2018 Q4	$1.31M	Buy	8,500 +5,100	+150%	+$794K	﹤0.01%	2838
2018 Q3	$511K	Sell	3,400 -14,100	-81%	-$2M	﹤0.01%	4257
2018 Q2	$2.37M	Sell	17,500 -7,500	-30%	-$926K	﹤0.01%	2412
2018 Q1	$3.33M	Buy	25,000 +2,000	+9%	+$269K	﹤0.01%	1963
2017 Q4	$3.42M	Buy	23,000 +3,000	+15%	+$408K	﹤0.01%	1950
2017 Q3	$2.64M	Buy	20,000 +9,200	+85%	+$1.24M	﹤0.01%	2081
2017 Q2	$1.44M	Sell	10,800 -4,300	-28%	-$580K	﹤0.01%	2553
2017 Q1	$2.04M	Buy	15,100 +1,100	+8%	+$142K	﹤0.01%	2084
2016 Q4	$1.68M	Buy	14,000 +5,100	+57%	+$601K	﹤0.01%	2269
2016 Q3	$1.11M	Sell	8,900 -6,200	-41%	-$812K	﹤0.01%	2530
2016 Q2	$2.09M	Buy	15,100 +8,000	+113%	+$1.04M	﹤0.01%	1970
2016 Q1	$895K	Sell	7,100 -2,600	-27%	-$330K	﹤0.01%	2615
2015 Q4	$1.22M	Buy	9,700 +2,200	+29%	+$273K	﹤0.01%	2423
2015 Q3	$863K	Buy	7,500 +300	+4%	+$33.7K	﹤0.01%	2876
2015 Q2	$749K	Sell	7,200 -7,200	-50%	-$777K	﹤0.01%	3134
2015 Q1	$1.58M	Sell	14,400 -7,100	-33%	-$771K	﹤0.01%	2540
2014 Q4	$2.24M	Buy	21,500 +5,300	+33%	+$530K	﹤0.01%	2426
2014 Q3	$1.55M	Sell	16,200 -27,200	-63%	-$2.46M	﹤0.01%	2907
2014 Q2	$3.95M	Sell	43,400 -25,200	-37%	-$2.26M	﹤0.01%	1973
2014 Q1	$6.04M	Buy	68,600 +35,800	+109%	+$3.14M	0.01%	1558
2013 Q4	$3.02M	Sell	32,800 -42,600	-56%	-$3.84M	﹤0.01%	2261
2013 Q3	$6.11M	Buy	75,400 +10,300	+16%	+$870K	0.01%	1525
2013 Q2	$5.41M	Buy	+65,100	New	+$5.6M	0.01%	1556

Other funds holding CLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Barclays's CLX Position: Q1 2026 in Review

Barclays increased its Clorox (CLX) stake by 16% in Q1 2026, buying an estimated $5.34M and bringing the position to 345,801 shares worth $35.8M. The position accounts for 0.01% of the portfolio, ranked #850.

Barclays first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $122M in Q2 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

Barclays held 345,801 shares of Clorox worth $35.8M as of Q1 2026.
Barclays bought 47,083 Clorox shares in Q1 2026, an estimated $5.34M.
Clorox made up 0.01% of Barclays's portfolio in Q1 2026, its #850 holding.
Barclays first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
Barclays's Clorox position peaked at $122M in Q2 2024.
1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.